Strong Revenue Growth:
Revenue is characterized by rapid expansion following the 2023 pivot to software, with multiple references to multi-fold growth in 2024 and continued scaling efforts into 2025. This pattern is presented alongside claims of outsized year-over-year increases tied to licensing its platform to providers.
Investor Backing & Capital Strength:
A $10M Series A led by F-Prime with participation from Y Combinator, Pear VC, and Lightbank provides fresh capital to fund product development and team expansion. The timing of the raise after the reported acceleration signals investor confidence in scaling the business.
Market Expansion:
Customer references now include large providers such as Cityblock Health, GrandCare, Baylor Scott & White Health, and Imagine Pediatrics. The company’s shift to licensing its platform and active hiring across functions suggest efforts to broaden market reach.